Share

Gene beats pancreatic cancer

accreditation
In research with mice, US scientists found that a mutant gene called Bik can shrink or kill pancreatic tumors. Bik produces a protein that forces cancer cells to kill themselves, said the University of Texas MD Anderson Cancer Centre team.

The finding, published this week in the journal Cancer Cell, offers hope for a new treatment for one of the deadliest human cancers, Agence France-Presse reported.

"This looks like a promising approach to gene therapy for pancreatic cancer and we are working to bring it to a clinical trial," said James Abbruzzese, professor and chairman of the department of gastrointestinal oncology at the MD Anderson Cancer Centre.

"There are no good options for pancreatic cancer patients now," said Abbruzzese, who estimated that it will take one to two years to complete US Food and Drug Administration requirements for a phase I clinical trial in humans, AFP reported.

About 96 percent of pancreatic cancer patients die within five years of diagnosis, one of the lowest cancer survival rates. – (HealthDayNews)

Read more:
Cancer stem cells spotted
Earlier pancreatic cancer diagnosis

July 2007

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE